News
CELZ
2.140
+2.39%
0.050
Creative Medical Technology Holdings Inc <CELZ.OQ> expected to post a loss of 40 cents a share - Earnings Preview
Reuters · 2d ago
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 2d ago
Creative Medical Technology Holds Special Stockholder Meeting
TipRanks · 5d ago
Creative Medical Technology Holdings Inc <CELZ.OQ> expected to post a loss of 52 cents a share - Earnings Preview
Reuters · 5d ago
Weekly Report: what happened at CELZ last week (0428-0502)?
Weekly Report · 6d ago
Weekly Report: what happened at CELZ last week (0421-0425)?
Weekly Report · 04/28 10:26
Weekly Report: what happened at CELZ last week (0414-0418)?
Weekly Report · 04/21 10:26
Weekly Report: what happened at CELZ last week (0407-0411)?
Weekly Report · 04/14 10:19
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 04/10 21:06
ANNUAL REPORT ON FORM 10-K For the Year Ended December 31, 2024
Press release · 04/07 13:54
Weekly Report: what happened at CELZ last week (0331-0404)?
Weekly Report · 04/07 10:19
Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders
Seeking Alpha · 04/02 21:05
Creative Medical Technology files to sell 1.8M shares of common for holders
TipRanks · 04/02 20:50
Weekly Report: what happened at CELZ last week (0324-0328)?
Weekly Report · 03/31 10:26
Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock?
NASDAQ · 03/25 16:00
Weekly Report: what happened at CELZ last week (0317-0321)?
Weekly Report · 03/24 10:19
Creative Medical Technology price target lowered to $26 from $30 at Roth MKM
TipRanks · 03/21 12:30
Creative Medical Technology Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 03/20 21:01
CREATIVE MEDICAL TECHNOLOGY HOLDINGS SECURES FDA CLEARANCE FOR EXPANDED DOSE ESCALATION IN THE CLINICAL TRIAL OF CELZ-201-DDT FOR CHRONIC LOWER BACK PAIN
Reuters · 03/20 11:50
Creative Medical Technology Holdings Inc <CELZ.OQ> expected to post a loss of 64 cents a share - Earnings Preview
Reuters · 03/18 20:10
More
Webull provides a variety of real-time CELZ stock news. You can receive the latest news about Creative Med Technology Hldgs through multiple platforms. This information may help you make smarter investment decisions.
About CELZ
More
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Recently
Symbol
Price
%Change